Skip to main content

Leadership Team

Our Leadership Team is comprised of dedicated cell and gene therapy experts with the GMP manufacturing know-how and regulatory understanding to drive your product from clinical trial to commercial supply for the global market.

Bev Menner
Chief Executive Officer

Bev is a pharmaceutical industry leader whose greatest strength lies in strategic relationship management – negotiating alliances and influencing people from diverse functions and companies to drive towards an aligned, mutually beneficial outcome. She has over 20 years’ experience in the bio/healthcare sector across geographies and functions including clinical, R&D, portfolio analysis & governance, strategy, business development, project management and alliance management.

A/Prof Dominic Wall
Chief Scientific Officer

Dominic oversees the quality and production nominees for the purposes of licensing by the Therapeutic Goods Administration (TGA). With over 20 years’ experience in this space, Dominic is an expert in CAR T-cell process development, analytics and production. At the Peter MacCallum Cancer Centre, Dominic has a joint appointment as the Executive Director for Business Ventures. He also provides executive oversight to the national Centre of Excellence in Cellular Immunotherapy. 

Kate MacCormack
Director of Human Resources 

Kate has 20 years of experience working in People and Culture roles across health, finance and professional services. She is passionate about supporting people to be their best at work and executes this through building strong relationships, understanding and alternative perspectives. 

Dr Wendy Fleming

Dr Wendy Fleming
Director of Production

Wendy is responsible for delivering projects manufactured in our GMP facility. Wendy’s PhD in Molecular Biology and experience in GMP facilities in academic research institutes led her to her position at Cell Therapies in 2010. 

Bindhu Radhakrishnan

Director Of Quality
Bindhu is a Risk and Security Management professional with over 15 years of experience in highly regulated pharma industry, pro-active and pragmatic risk management and is a subject matter expert in Governance, Risk and Compliance. In addition she has substantial experience in Information Security, Internal and External audits, Third Party oversight, IT Quality Assurance and Regulatory Compliance.

Nathan Smith

Nathan Smith

Director of Business Development 
Nathan oversees business development, and collaboration activities, and manages the client pipeline at Cell Therapies. He has over 20 years of experience within the cell therapy and biopharma industries, with strong expertise in GMP clinical and commercial manufacturing.

Vy Nguyen

Vy Nguyen

Contract Relationship Manager
With over 30 years of BioPharma operations experience, Vy is a key point of contact between Cell Therapies Pty Ltd and our clients. He is responsible for building and maintaining collaborative relationships with clients while working with internal stakeholders to deliver our clients’ business needs.

Behind the Scenes

Our team of experts spans the medical, healthcare, and scientific communities, driving the development and commercialization of groundbreaking cell and gene therapies.

Our Board

Extensive experience across the Australian healthcare and medical sector, and biotechnology industry.

Scientific Advisors

Expertise and knowledge from across the cell and gene therapy, health, and medical sectors